5 active not recruiting, 3 recruiting, 2 completed, 2 terminated. 13 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Active not recruiting 5, Recruiting 3, Completed 2, Terminated 2, Not yet recruiting 1 |
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Diagnostic Imaging: new trials by email Literature Review of Diagnostic Imaging trials Research Report on Diagnostic Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 31 | 2027-06-01 | 2026-10-22 |
| Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Malignant Solid Neoplasm, Recurrent Childhood Neuroblastoma | Phase 1 / Phase 2 | Not yet recruiting | Children's Oncology Group | 77 | 2027-04-09 | 2026-09-15 |
| Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer Biospecimen Collection, Cholestyramine, Computed Tomography - Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 | Phase 1 | Active not recruiting | City of Hope Medical Center | 19 | 2024-06-10 | 2026-11-10 |
| Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Recruiting | National Cancer Institute (NCI) | 45 | 2023-08-10 | 2026-11-12 |
| Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm | Phase 1 | Recruiting | National Cancer Institute (NCI) | 43 | 2023-07-06 | 2026-08-03 |
| Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis Pre-operative abemaciclib, Device for Cerebral Fluid Dialysate Collection, Ashion Analytics GEM ExTra - Glioma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 5 | 2023-04-07 | 2026-10-06 |
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR - Kita-kyushu Lung Cancer Antigen 1, Human | Phase 1 | Terminated | National Cancer Institute (NCI) | 36 | 2022-03-08 | 2025-12-02 |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 10 | 2021-08-13 | 2026-11-13 |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 14 | 2021-06-01 | 2026-11-13 |
| Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer Abemaciclib, Biopsy Procedure, Biospecimen Collection - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 24 | 2020-06-17 | 2026-11-13 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients Cyclophosphamide, Fludarabine, Aldesleukin - Gastrointestinal Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2019-05-16 | 2026-05-19 |
| Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer Glutaminase Inhibitor CB-839, Panitumumab, Irinotecan Hydrochloride (phase I only) - Colorectal Cancer, Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 29 | 2017-08-23 | 2024-08-30 |
| Tissue Oxygenation Measurements With Modulated Light (S-FLARE) Imaging with S-FLARE imaging system - Breast Cancer | Phase 1 | Completed | Beth Israel Deaconess Medical Center | 4 | 2010-01-01 | 2013-02-18 |
Pancreatic Neoplasms (4) · Breast Neoplasms (3) · Neoplasm Metastasis (3) · Colorectal Neoplasms (2) · Stomach Neoplasms (2) · Brain Neoplasms (1) · Carcinoma (1) · Colonic Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gastrointestinal Neoplasms (1) · Glioma (1) · Ovarian Neoplasms (1) · Rectal Neoplasms (1) · Triple Negative Breast Neoplasms (1)
National Cancer Institute (NCI) (9) · Beth Israel Deaconess Medical Center (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · Vanderbilt-Ingram Cancer Center (1)
United States (12) · Canada (1)
Amit J Sabnis (1) · Cynthia X Ma (1) · Geoffrey I Shapiro (1) · James C Yang, M.D. (1) · James M Cleary (1) · Jia Luo (1) · John V. Frangioni, MD, PhD (1) · Jordan Berlin, MD (1) · Liza C Villaruz (1) · Sadhana Jackson, M.D. (1) · Scott M Norberg, D.O. (1) · Vincent Chung (1)
UM1CA186709 (3), UM1CA186689 (2), P30CA033572 (1), UM1CA186690 (1), UM1CA186704 (1), UM1CA228823 (1)